Chromosome aberrations in workers exposed to organic solvents: Influence of polymorphisms in xenobiotic-metabolism and DNA repair genes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 666, Issue 1-2, 2009, Pages 8-15

  Hoyos Giraldo, Luz Stella ^a   Carvajal, Silvio ^a   Cajas Salazar, Nohelia ^a   Ruíz, Martín ^a   Sánchez Gómez, Adalberto ^b  

^a UNIVERSIDAD DEL CAUCA   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Chromosome aberrations; Genetic polymorphisms; Occupational exposure; Organic solvents; Susceptibility; Xenobiotic metabolism and DNA repair genes

Indexed keywords

ARGININE; BIOLOGICAL MARKER; CYTOCHROME P450 2E1; DNA; GLUTAMINE; GLUTATHIONE TRANSFERASE M1; HISTIDINE; METHIONINE; ORGANIC SOLVENT; THREONINE; TRYPTOPHAN; XRCC1 PROTEIN;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA REPAIR; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; WORKER; XENOBIOTIC METABOLISM;

ADULT; CHROMOSOME ABERRATIONS; DNA REPAIR; DNA REPAIR ENZYMES; HUMANS; MALE; OCCUPATIONAL EXPOSURE; ORGANIC CHEMICALS; POLYMORPHISM, GENETIC; SOLVENTS; TIME FACTORS; XENOBIOTICS;

EID: 67349101985     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.03.003     Document Type: Article

References (77)

1. IARC. Occupational exposures in paint manufacture and painting. In: IARC (Ed). Monographs in Evaluation Carcinogenic Risk in Humans (1989), International Agency for the Research on Cancer, Lyon
2. Lynge E., Anttila A., and Hemminki K. Organic solvents and cancer. Cancer Causes Control 8 (1997) 406-419
3. Bogadi-Sare A., Brumen V., Turk R., Karacic V., and Zavalic M. Genotoxic effects in workers exposed to benzene: with special reference to exposure biomarkers and confounding factors. Ind. Health 35 (1997) 367-373
4. Aksoy H., Yilmaz S., Celik M., Yuzbasioglu D., and Unal F. Genotoxicity study in lymphocytes of offset printing workers. J. Appl. Toxicol. 26 (2006) 10-15
5. Bonassi S., Hagmar L., Stromberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkila P., Wanders S., Wilhardt P., Hansteen I.L., Knudsen L.E., and Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60 (2000) 1619-1625
6. Hagmar L., Stromberg U., Bonassi S., Hansteen I.L., Knudsen L.E., Lindholm C., and Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res. 64 (2004) 2258-2263
7. Valentine J.L., Lee S.S.T., Seaton M.J., Asgharian B., Farris G., Corton J.C., Gonzalez F.J., and Medinsky M.A. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141 (1996) 205-213
8. Hayashi S., Watanabe J., and Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. (Tokyo) 110 (1991) 559-565
9. Cajas-Salazar N., Sierra-Torres C.H., Salama S.A., Zwischenberger J.B., and Au W.W. Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk. Int. J. Hyg. Environ. Health 206 (2003) 473-483
10. Pandey A., Bajpayee M., Parmar D., Kumar R., Rastogi S., Mathur N., Thorning P., de Matas M., Shao Q., and Anderson D. Multipronged evaluation of genotoxicity in Indian petrol-pump workers. Environ. Mol. Mutagen. 49 (2008) 000-10
11. Ross D. The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J. Toxicol. Environ. Health A 61 (2000) 357-372
12. Zhang L., Robertson M.L., Kolachana P., Davison A.J., and Smith M.T. Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ. Mol. Mutagen. 21 (1993) 339-348
13. Kim S.Y., Choi J.K., Cho Y.H., Chung E.J., Paek D., and Chung H.W. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 14 (2004) 453-463
14. Kirsch-Volders M., Mateuca R.A., Roelants M., Tremp A., Zeiger E., Bonassi S., Holland N., Chang W.P., Aka P.V., Deboeck M., Godderis L., Haufroid V., Ishikawa H., Laffon B., Marcos R., Migliore L., Norppa H., Teixeira J.P., Zijno A., and Fenech M. The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiol. Biomark. Prev. 15 (2006) 1038-1042
15. Pemble S.E., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., and Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300 Pt 1 (1994) 271-276
16. da Silva J., Moraes C.R., Heuser V.D., Andrade V.M., Silva F.R., Kvitko K., Emmel V., Rohr P., Bordin D.L., Andreazza A.C., Salvador M., Henriques J.A., and Erdtmann B. Evaluation of genetic damage in a Brazilian population occupationally exposed to pesticides and its correlation with polymorphisms in metabolizing genes. Mutagenesis 23 (2008) 415-422
17. Wilson III D.M., and Thompson L.H. Life without DNA repair. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12754-12757
18. Brenneman M.A., Wagener B.M., Miller C.A., Allen C., and Nickoloff J.A. XRCC3 controls the fidelity of homologous recombination: roles for XRCC3 in late stages of recombination. Mol. Cell 10 (2002) 387-395
19. Brem R., and Hall J. XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res. 33 (2005) 2512-2520
20. Nazarkina Z.K., Khodyreva S.N., Marsin S., Lavrik O.I., and Radicella J.P. XRCC1 interactions with base excision repair DNA intermediates. DNA Repair 6 (2007) 254-264
21. Kuzminov A. Single-strand interruptions in replicating chromosomes cause double-strand breaks. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8241-8246
22. Pfeiffer P., Goedecke W., and Obe G. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15 (2000) 289-302
23. Shen M.R., Jones I.M., and Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58 (1998) 604-608
24. Benhamou S., and Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res. 462 (2000) 149-158
25. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 149 (2004) 309-334
26. WHO guideline of obtaining informed consent for the procurement and use of human tissues, cells, and fluids in research, in: S.a.E.R.G. (SERG) (Ed.), 2003.
27. W.M. Association Declaration of Helsinki, Ethical principles for medical research involving human subjects, in: W.M. Association Declaration of Helsinki (Ed.), Proceedings of the 18th World Medical Association General Assembly, Helsinki, Finland, 1964.
28. IAEA. Cytogenetic analysis for radiation dose assessment. In: IAEA (Ed). Technical Reports Series (2001), IAEA, Vienna 1-138
29. Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., Natarajan A.T., Norppa H., Shuker D.E.G., Tice R., Waters M.D., and Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat. Res./Rev. Mutat. Res. 463 (2000) 111-172
30. Abdel-Rahman S.Z., ElZein R.A., Anwar W.A., and Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107 (1996) 229-233
31. Anwar W.A., Abdel-Rahman S.Z., el Zein R.A., Mostafa H.M., and Au W.W. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17 (1996) 1923-1929
32. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59 (1999) 2557-2561
33. Tuimala J., Szekely G., Gundy S., Hirvonen A., and Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 23 (2002) 1003-1008
34. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1513-1530
35. Duarte M.C., Colombo J., Rossit A.R., Caetano A., Borim A.A., Wornrath D., and Silva A.E. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J. Gastroenterol. 11 (2005) 6593-6600
36. Bukvic N., Bavaro P., Elia G., Cassano F., Fanelli M., and Guanti G. Sister chromatid exchange (SCE) and micronucleus (MN) frequencies in lymphocytes of gasoline station attendants. Mutat. Res. - Genet. Toxicol. Environ. Mutagen. 415 (1998) 25-33
37. Pathiratne A., Puyear R., and Brammer J. A comparative study of the effects of benzene, toluene, and xylenes on their in vitro metabolism and drug-metabolizing enzymes in rat liver. Toxicol. Appl. Pharmacol. 82 (1986) 272-280
38. Sul D.G., Lee D., Im H., Oh E., Kim J., and Lee E. Single strand DNA breaks in T- and B-lymphocytes and granulocytes in workers exposed to benzene. Toxicol. Lett. 134 (2002) 87-95
39. Vainio H., Waters M.D., and Norppa H. Mutagenicity of selected organic solvents. Scand. J. Work Environ. Health 11 Suppl. 1 (1985) 75-82
40. Fishbein L. Genetic effects of benzene, toluene and xylene. IARC Sci. Publ. (1988) 19-46
41. Silva J.M., and Santos-Mello R. Chromosomal aberrations in lymphocytes from car painters. Mutat. Res. 368 (1996) 21-25
42. Kasuba V., Rozgaj R., and Sentija K. Cytogenetic changes in subjects occupationally exposed to benzene. Chemosphere 40 February (3) (2000) 307-310
43. Pinto D., Ceballos J.M., Garcia G., Guzman P., Del Razo L.M., Vera E., Gomez H., Garcia A., and Gonsebatt M.E. Increased cytogenetic damage in outdoor painters. Mutat. Res. 467 (2000) 105-111
44. Pitarque M., Vaglenov A., Nosko M., Pavlova S., Petkova V., Hirvonen A., Creus A., Norppa H., and Marcos R. Sister chromatid exchanges and micronuclei in peripheral lymphocytes of shoe factory workers exposed to solvents. Environ. Health Perspect. 110 (2002) 399-404
45. Martinez-Alfaro M., Palma-Tirado L., Sandoval-Zapata F., and Carabez-Trejo A. Correlation between formamidopyrimidine DNA glycosylase (Fpg)-sensitive sites determined by a comet assay, increased MDA, and decreased glutathione during long exposure to thinner inhalation. Toxicol. Lett. 163 (2006) 198-205
46. Moszczynski P., Lisiewicz J., and Slowinski S. Synergistic effect of organic solvents and tobacco smoke on serum immunoglobulin levels in humans. Med. Pr. 40 (1989) 337-341
47. Kramers P.G., and Roelfzema H. Classification of chemicals for carcinogenic and mutagenic properties. Toxicol. Lett. 64-65 (1992) 173-182
48. Sasiadek M., and Jagielski J. Genotoxic effects observed in workers occupationally exposed to organic solvents. Pol. J. Occup. Med. 3 (1990) 103-108
49. Kim Y.J., Choi J.Y., Paek D., and Chung H.W. Association of the NQO1, MPO, and XRCC1 polymorphisms and chromosome damage among workers at a petroleum refinery. J. Toxicol. Environ. Health A 71 (2008) 333-341
50. Mateuca R., Lombaert N., Aka P.V., Decordier I., and Kirsch-Volders M. Chromosomal changes: induction, detection methods and applicability in human biomonitoring. Biochimie 88 (2006) 1515-1531
51. Hoyos-Giraldo L.S. Genotoxicidad de los Plaguicidas: Mutagnicidad, Carcinogenicidad y Teratogenicidad. In: Córdoba D. (Ed). Toxicología (2006), Editorial El Manual Moderno, Bogotá 1022
52. Hoyos-Giraldo L.S. Exposición Ocupacional, Biomarcadores de Riesgo de Cáncer en los Programas de Vigilancia Epidemiológica Ocupacional para la Prevención. Salud Mental 38 (2006) 96
53. Cardenas-Bustamante O., Varona-Uribe M., Patino-Florez R.I., Groot-Restrepo H., Sicard-Suarez D., Torres-Carvajal M.M., and Pardo-Pardo D. Bogota paint-industry workers exposure to organic solvents and genotoxic effects. Rev. Salud Publ. 9 (2007) 275-288
54. Kim S.Y., Choi J.K., Cho Y.H., Chung E.J., Paek D., and Chung H.W. Chromosomal aberrations in workers exdosed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 14 (2004) 453-463
55. Musak L., Soucek P., Vodickova L., Naccarati A., Halasova E., Polakova V., Slyskova J., Susova S., Buchancova J., Smerhovsky Z., Sedikova J., Klimentova G., Osina O., Hemminki K., and Vodicka P. Chromosomal aberrations in tire plant workers and interaction with polymorphisms of biotransformation and DNA repair genes. Mutat. Res. 641 (2008) 36-42
56. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le M.L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stucker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., and Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1239-1248
57. Gruber S.B. Population stratification in epidemiologic studies of founder populations. Cancer Biomark. 3 (2007) 123-128
58. Boccia S., Cadoni G., Sayed-Tabatabaei F.A., Volante M., Arzani D., De Lauretis A., Cattel C., Almadori G., van Duijn C.M., Paludetti G., and Ricciardi G. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J. Cancer Res. Clin. Oncol. 134 (2008) 93-100
59. Xu X., Wiencke J.K., Niu T., Wang M., Watanabe H., Kelsey K.T., and Christiani D.C. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am. J. Ind. Med. 33 (1998) 157-163
60. Heuser V.D., Erdtmann B., Kvitko K., Rohr P., and da Silva J. Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility. Toxicology 232 (2007) 235-247
61. Carlsten C., Sagoo G.S., Frodsham A.J., Burke W., and Higgins J.P. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am. J. Epidemiol. 167 (2008) 759-774
62. Parl F.F. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 221 (2005) 123-129
63. Pitarque M., Vaglenov A., Nosko M., Pavlova S., Petkova V., Hirvonen A., Creus A., Norppa H., and Marcos R. Sister chromatid exchanges and micronuclei in peripheral lymphocytes of shoe factory workers exposed to solvents. Environ. Health Perspect. 110 April (4) (2002) 399-404
64. Cajas-Salazar N., Sierra-Torres C.H., Salama S.A., Zwischenberger J.B., and Au W.W. Combined effect of MP0, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk. Int. J. Hyg. Environ. Health 206 (2003) 473-483
65. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., Mark E.J., Wain J.C., Christiani D.C., and Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21 (2000) 965-971
66. Zhu S.M., Xia Z.L., Wang A.H., Ren X.F., Jiao J., Zhao N.Q., Qian J., Jin L., and Christiani D.C. Polymorphisms and haplotypes of DNA repair and xenobiotic metabolism genes and risk of DNA damage in Chinese vinyl chloride monomer (VCM)-exposed workers. Toxicol. Lett. 178 (2008) 88-94
67. Zhang Z.B., Wan J.X., Jin X.P., Jin T.Y., Shen H.B., Lu D.R., and Xia Z.L. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomark. Prev. 14 (2005) 2614-2619
68. Ramachandran S., Ramadas K., Hariharan R., Rejnish Kumar R., and Radhakrishna Pillai M. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 42 (2006) 350-362
69. Tuimala J., Szekely G., Wikman H., Jarventaus H., Hirvonen A., Gundy S., and Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat. Res. 554 October (1-2) (2004) 319-333
70. Mateuca R.A., Roelants M., Iarmarcovai G., Aka P.V., Godderis L., Tremp A., Bonassi S., Fenech M., Berge-Lefranc J.L., and Kirsch-Volders M. hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23 (2008) 35-41
71. Xu J., Yang M., Huang H., Wang Q., et al. Association between genetic polymorphisms of DNA repair genes XRCC1, XPD, XRCC3 and the capacity of DNA repair induce by benzene. Wei Sheng Yan Jiu 36 (2007) 529-532
72. Chanvaivit S., Navasumrit P., Hunsonti P., Autrup H., and Ruchirawat M. Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 626 (2007) 79-87
73. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect. 105 Suppl. 4 (1997) 829-835
74. Hirvonen A. Gene-environment interaction and biological monitoring of occupational exposures. Toxicol. Appl. Pharmacol. 207 (2005) 329-335
75. Bonassi S., and Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511 (2002) 73-86
76. Angerer J., Ewers U., and Wilhelm M. Human biomonitoring: state of the art. Int. J. Hyg. Environ. Health 210 (2007) 201-228
77. Krajinovic M., Labuda D., Mathonnet G., Labuda M., Moghrabi A., Champagne J., and Sinnett D. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin. Cancer Res. 8 (2002) 802-810